Global Influenza Drugs and Vaccines Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Influenza Drugs and Vaccines Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Influenza Drugs and Vaccines by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Influenza Drugs and Vaccines by Country/Region, 2017, 2022 & 2028

2.2 Influenza Drugs and Vaccines Segment by Type

2.2.1 Influenza Drugs

2.2.2 Influenza Vaccines

2.3 Influenza Drugs and Vaccines Sales by Type

2.3.1 Global Influenza Drugs and Vaccines Sales Market Share by Type (2017-2022)

2.3.2 Global Influenza Drugs and Vaccines Revenue and Market Share by Type (2017-2022)

2.3.3 Global Influenza Drugs and Vaccines Sale Price by Type (2017-2022)

2.4 Influenza Drugs and Vaccines Segment by Application

2.4.1 Hospital Pharmacy

2.4.2 Retail Pharmacy

2.4.3 Online Pharmacy

2.5 Influenza Drugs and Vaccines Sales by Application

2.5.1 Global Influenza Drugs and Vaccines Sale Market Share by Application (2017-2022)

2.5.2 Global Influenza Drugs and Vaccines Revenue and Market Share by Application (2017-2022)

2.5.3 Global Influenza Drugs and Vaccines Sale Price by Application (2017-2022)

3 Global Influenza Drugs and Vaccines by Company

3.1 Global Influenza Drugs and Vaccines Breakdown Data by Company

3.1.1 Global Influenza Drugs and Vaccines Annual Sales by Company (2020-2022)

3.1.2 Global Influenza Drugs and Vaccines Sales Market Share by Company (2020-2022)

3.2 Global Influenza Drugs and Vaccines Annual Revenue by Company (2020-2022)

3.2.1 Global Influenza Drugs and Vaccines Revenue by Company (2020-2022)

3.2.2 Global Influenza Drugs and Vaccines Revenue Market Share by Company (2020-2022)

3.3 Global Influenza Drugs and Vaccines Sale Price by Company

3.4 Key Manufacturers Influenza Drugs and Vaccines Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Influenza Drugs and Vaccines Product Location Distribution

3.4.2 Players Influenza Drugs and Vaccines Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Influenza Drugs and Vaccines by Geographic Region

4.1 World Historic Influenza Drugs and Vaccines Market Size by Geographic Region (2017-2022)

4.1.1 Global Influenza Drugs and Vaccines Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Influenza Drugs and Vaccines Annual Revenue by Geographic Region

4.2 World Historic Influenza Drugs and Vaccines Market Size by Country/Region (2017-2022)

4.2.1 Global Influenza Drugs and Vaccines Annual Sales by Country/Region (2017-2022)

4.2.2 Global Influenza Drugs and Vaccines Annual Revenue by Country/Region

4.3 Americas Influenza Drugs and Vaccines Sales Growth

4.4 APAC Influenza Drugs and Vaccines Sales Growth

4.5 Europe Influenza Drugs and Vaccines Sales Growth

4.6 Middle East & Africa Influenza Drugs and Vaccines Sales Growth

5 Americas

5.1 Americas Influenza Drugs and Vaccines Sales by Country

5.1.1 Americas Influenza Drugs and Vaccines Sales by Country (2017-2022)

5.1.2 Americas Influenza Drugs and Vaccines Revenue by Country (2017-2022)

5.2 Americas Influenza Drugs and Vaccines Sales by Type

5.3 Americas Influenza Drugs and Vaccines Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Influenza Drugs and Vaccines Sales by Region

6.1.1 APAC Influenza Drugs and Vaccines Sales by Region (2017-2022)

6.1.2 APAC Influenza Drugs and Vaccines Revenue by Region (2017-2022)

6.2 APAC Influenza Drugs and Vaccines Sales by Type

6.3 APAC Influenza Drugs and Vaccines Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Influenza Drugs and Vaccines by Country

7.1.1 Europe Influenza Drugs and Vaccines Sales by Country (2017-2022)

7.1.2 Europe Influenza Drugs and Vaccines Revenue by Country (2017-2022)

7.2 Europe Influenza Drugs and Vaccines Sales by Type

7.3 Europe Influenza Drugs and Vaccines Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Influenza Drugs and Vaccines by Country

8.1.1 Middle East & Africa Influenza Drugs and Vaccines Sales by Country (2017-2022)

8.1.2 Middle East & Africa Influenza Drugs and Vaccines Revenue by Country (2017-2022)

8.2 Middle East & Africa Influenza Drugs and Vaccines Sales by Type

8.3 Middle East & Africa Influenza Drugs and Vaccines Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Influenza Drugs and Vaccines

10.3 Manufacturing Process Analysis of Influenza Drugs and Vaccines

10.4 Industry Chain Structure of Influenza Drugs and Vaccines

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Influenza Drugs and Vaccines Distributors

11.3 Influenza Drugs and Vaccines Customer

12 World Forecast Review for Influenza Drugs and Vaccines by Geographic Region

12.1 Global Influenza Drugs and Vaccines Market Size Forecast by Region

12.1.1 Global Influenza Drugs and Vaccines Forecast by Region (2023-2028)

12.1.2 Global Influenza Drugs and Vaccines Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Influenza Drugs and Vaccines Forecast by Type

12.7 Global Influenza Drugs and Vaccines Forecast by Application

13 Key Players Analysis

13.1 Bristol Myers Squibb

13.1.1 Bristol Myers Squibb Company Information

13.1.2 Bristol Myers Squibb Influenza Drugs and Vaccines Product Offered

13.1.3 Bristol Myers Squibb Influenza Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Bristol Myers Squibb Main Business Overview

13.1.5 Bristol Myers Squibb Latest Developments

13.2 AstraZeneca

13.2.1 AstraZeneca Company Information

13.2.2 AstraZeneca Influenza Drugs and Vaccines Product Offered

13.2.3 AstraZeneca Influenza Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 AstraZeneca Main Business Overview

13.2.5 AstraZeneca Latest Developments

13.3 Eli Lilly

13.3.1 Eli Lilly Company Information

13.3.2 Eli Lilly Influenza Drugs and Vaccines Product Offered

13.3.3 Eli Lilly Influenza Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Eli Lilly Main Business Overview

13.3.5 Eli Lilly Latest Developments

13.4 Roche

13.4.1 Roche Company Information

13.4.2 Roche Influenza Drugs and Vaccines Product Offered

13.4.3 Roche Influenza Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Roche Main Business Overview

13.4.5 Roche Latest Developments

13.5 GlaxoSmithKline

13.5.1 GlaxoSmithKline Company Information

13.5.2 GlaxoSmithKline Influenza Drugs and Vaccines Product Offered

13.5.3 GlaxoSmithKline Influenza Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 GlaxoSmithKline Main Business Overview

13.5.5 GlaxoSmithKline Latest Developments

13.6 Novartis

13.6.1 Novartis Company Information

13.6.2 Novartis Influenza Drugs and Vaccines Product Offered

13.6.3 Novartis Influenza Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Novartis Main Business Overview

13.6.5 Novartis Latest Developments

13.7 Pfizer

13.7.1 Pfizer Company Information

13.7.2 Pfizer Influenza Drugs and Vaccines Product Offered

13.7.3 Pfizer Influenza Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Pfizer Main Business Overview

13.7.5 Pfizer Latest Developments

13.8 Sanofi Pasteur

13.8.1 Sanofi Pasteur Company Information

13.8.2 Sanofi Pasteur Influenza Drugs and Vaccines Product Offered

13.8.3 Sanofi Pasteur Influenza Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Sanofi Pasteur Main Business Overview

13.8.5 Sanofi Pasteur Latest Developments

13.9 Bayer

13.9.1 Bayer Company Information

13.9.2 Bayer Influenza Drugs and Vaccines Product Offered

13.9.3 Bayer Influenza Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Bayer Main Business Overview

13.9.5 Bayer Latest Developments

13.10 Celgene

13.10.1 Celgene Company Information

13.10.2 Celgene Influenza Drugs and Vaccines Product Offered

13.10.3 Celgene Influenza Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Celgene Main Business Overview

13.10.5 Celgene Latest Developments

13.11 Seqirus

13.11.1 Seqirus Company Information

13.11.2 Seqirus Influenza Drugs and Vaccines Product Offered

13.11.3 Seqirus Influenza Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Seqirus Main Business Overview

13.11.5 Seqirus Latest Developments

13.12 Protein Sciences Corporation

13.12.1 Protein Sciences Corporation Company Information

13.12.2 Protein Sciences Corporation Influenza Drugs and Vaccines Product Offered

13.12.3 Protein Sciences Corporation Influenza Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Protein Sciences Corporation Main Business Overview

13.12.5 Protein Sciences Corporation Latest Developments

13.13 Serum Institute of India

13.13.1 Serum Institute of India Company Information

13.13.2 Serum Institute of India Influenza Drugs and Vaccines Product Offered

13.13.3 Serum Institute of India Influenza Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Serum Institute of India Main Business Overview

13.13.5 Serum Institute of India Latest Developments

13.14 Emergent Biosolutions

13.14.1 Emergent Biosolutions Company Information

13.14.2 Emergent Biosolutions Influenza Drugs and Vaccines Product Offered

13.14.3 Emergent Biosolutions Influenza Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Emergent Biosolutions Main Business Overview

13.14.5 Emergent Biosolutions Latest Developments

13.15 BioCryst Pharmaceuticals

13.15.1 BioCryst Pharmaceuticals Company Information

13.15.2 BioCryst Pharmaceuticals Influenza Drugs and Vaccines Product Offered

13.15.3 BioCryst Pharmaceuticals Influenza Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 BioCryst Pharmaceuticals Main Business Overview

13.15.5 BioCryst Pharmaceuticals Latest Developments

13.16 Alvogen

13.16.1 Alvogen Company Information

13.16.2 Alvogen Influenza Drugs and Vaccines Product Offered

13.16.3 Alvogen Influenza Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Alvogen Main Business Overview

13.16.5 Alvogen Latest Developments

14 Research Findings and Conclusion

Table 1. Influenza Drugs and Vaccines Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Influenza Drugs and Vaccines Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Influenza Drugs

Table 4. Major Players of Influenza Vaccines

Table 5. Global Influenza Drugs and Vaccines Sales by Type (2017-2022) & (MT)

Table 6. Global Influenza Drugs and Vaccines Sales Market Share by Type (2017-2022)

Table 7. Global Influenza Drugs and Vaccines Revenue by Type (2017-2022) & ($ million)

Table 8. Global Influenza Drugs and Vaccines Revenue Market Share by Type (2017-2022)

Table 9. Global Influenza Drugs and Vaccines Sale Price by Type (2017-2022) & (USD/Kg)

Table 10. Global Influenza Drugs and Vaccines Sales by Application (2017-2022) & (MT)

Table 11. Global Influenza Drugs and Vaccines Sales Market Share by Application (2017-2022)

Table 12. Global Influenza Drugs and Vaccines Revenue by Application (2017-2022)

Table 13. Global Influenza Drugs and Vaccines Revenue Market Share by Application (2017-2022)

Table 14. Global Influenza Drugs and Vaccines Sale Price by Application (2017-2022) & (USD/Kg)

Table 15. Global Influenza Drugs and Vaccines Sales by Company (2020-2022) & (MT)

Table 16. Global Influenza Drugs and Vaccines Sales Market Share by Company (2020-2022)

Table 17. Global Influenza Drugs and Vaccines Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Influenza Drugs and Vaccines Revenue Market Share by Company (2020-2022)

Table 19. Global Influenza Drugs and Vaccines Sale Price by Company (2020-2022) & (USD/Kg)

Table 20. Key Manufacturers Influenza Drugs and Vaccines Producing Area Distribution and Sales Area

Table 21. Players Influenza Drugs and Vaccines Products Offered

Table 22. Influenza Drugs and Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Influenza Drugs and Vaccines Sales by Geographic Region (2017-2022) & (MT)

Table 26. Global Influenza Drugs and Vaccines Sales Market Share Geographic Region (2017-2022)

Table 27. Global Influenza Drugs and Vaccines Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Influenza Drugs and Vaccines Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Influenza Drugs and Vaccines Sales by Country/Region (2017-2022) & (MT)

Table 30. Global Influenza Drugs and Vaccines Sales Market Share by Country/Region (2017-2022)

Table 31. Global Influenza Drugs and Vaccines Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Influenza Drugs and Vaccines Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Influenza Drugs and Vaccines Sales by Country (2017-2022) & (MT)

Table 34. Americas Influenza Drugs and Vaccines Sales Market Share by Country (2017-2022)

Table 35. Americas Influenza Drugs and Vaccines Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Influenza Drugs and Vaccines Revenue Market Share by Country (2017-2022)

Table 37. Americas Influenza Drugs and Vaccines Sales by Type (2017-2022) & (MT)

Table 38. Americas Influenza Drugs and Vaccines Sales Market Share by Type (2017-2022)

Table 39. Americas Influenza Drugs and Vaccines Sales by Application (2017-2022) & (MT)

Table 40. Americas Influenza Drugs and Vaccines Sales Market Share by Application (2017-2022)

Table 41. APAC Influenza Drugs and Vaccines Sales by Region (2017-2022) & (MT)

Table 42. APAC Influenza Drugs and Vaccines Sales Market Share by Region (2017-2022)

Table 43. APAC Influenza Drugs and Vaccines Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Influenza Drugs and Vaccines Revenue Market Share by Region (2017-2022)

Table 45. APAC Influenza Drugs and Vaccines Sales by Type (2017-2022) & (MT)

Table 46. APAC Influenza Drugs and Vaccines Sales Market Share by Type (2017-2022)

Table 47. APAC Influenza Drugs and Vaccines Sales by Application (2017-2022) & (MT)

Table 48. APAC Influenza Drugs and Vaccines Sales Market Share by Application (2017-2022)

Table 49. Europe Influenza Drugs and Vaccines Sales by Country (2017-2022) & (MT)

Table 50. Europe Influenza Drugs and Vaccines Sales Market Share by Country (2017-2022)

Table 51. Europe Influenza Drugs and Vaccines Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Influenza Drugs and Vaccines Revenue Market Share by Country (2017-2022)

Table 53. Europe Influenza Drugs and Vaccines Sales by Type (2017-2022) & (MT)

Table 54. Europe Influenza Drugs and Vaccines Sales Market Share by Type (2017-2022)

Table 55. Europe Influenza Drugs and Vaccines Sales by Application (2017-2022) & (MT)

Table 56. Europe Influenza Drugs and Vaccines Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Influenza Drugs and Vaccines Sales by Country (2017-2022) & (MT)

Table 58. Middle East & Africa Influenza Drugs and Vaccines Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Influenza Drugs and Vaccines Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Influenza Drugs and Vaccines Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Influenza Drugs and Vaccines Sales by Type (2017-2022) & (MT)

Table 62. Middle East & Africa Influenza Drugs and Vaccines Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Influenza Drugs and Vaccines Sales by Application (2017-2022) & (MT)

Table 64. Middle East & Africa Influenza Drugs and Vaccines Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Influenza Drugs and Vaccines

Table 66. Key Market Challenges & Risks of Influenza Drugs and Vaccines

Table 67. Key Industry Trends of Influenza Drugs and Vaccines

Table 68. Influenza Drugs and Vaccines Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Influenza Drugs and Vaccines Distributors List

Table 71. Influenza Drugs and Vaccines Customer List

Table 72. Global Influenza Drugs and Vaccines Sales Forecast by Region (2023-2028) & (MT)

Table 73. Global Influenza Drugs and Vaccines Sales Market Forecast by Region

Table 74. Global Influenza Drugs and Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Influenza Drugs and Vaccines Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Influenza Drugs and Vaccines Sales Forecast by Country (2023-2028) & (MT)

Table 77. Americas Influenza Drugs and Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Influenza Drugs and Vaccines Sales Forecast by Region (2023-2028) & (MT)

Table 79. APAC Influenza Drugs and Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Influenza Drugs and Vaccines Sales Forecast by Country (2023-2028) & (MT)

Table 81. Europe Influenza Drugs and Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Influenza Drugs and Vaccines Sales Forecast by Country (2023-2028) & (MT)

Table 83. Middle East & Africa Influenza Drugs and Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Influenza Drugs and Vaccines Sales Forecast by Type (2023-2028) & (MT)

Table 85. Global Influenza Drugs and Vaccines Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Influenza Drugs and Vaccines Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Influenza Drugs and Vaccines Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Influenza Drugs and Vaccines Sales Forecast by Application (2023-2028) & (MT)

Table 89. Global Influenza Drugs and Vaccines Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Influenza Drugs and Vaccines Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Influenza Drugs and Vaccines Revenue Market Share Forecast by Application (2023-2028)

Table 92. Bristol Myers Squibb Basic Information, Influenza Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 93. Bristol Myers Squibb Influenza Drugs and Vaccines Product Offered

Table 94. Bristol Myers Squibb Influenza Drugs and Vaccines Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 95. Bristol Myers Squibb Main Business

Table 96. Bristol Myers Squibb Latest Developments

Table 97. AstraZeneca Basic Information, Influenza Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 98. AstraZeneca Influenza Drugs and Vaccines Product Offered

Table 99. AstraZeneca Influenza Drugs and Vaccines Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 100. AstraZeneca Main Business

Table 101. AstraZeneca Latest Developments

Table 102. Eli Lilly Basic Information, Influenza Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 103. Eli Lilly Influenza Drugs and Vaccines Product Offered

Table 104. Eli Lilly Influenza Drugs and Vaccines Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 105. Eli Lilly Main Business

Table 106. Eli Lilly Latest Developments

Table 107. Roche Basic Information, Influenza Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 108. Roche Influenza Drugs and Vaccines Product Offered

Table 109. Roche Influenza Drugs and Vaccines Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 110. Roche Main Business

Table 111. Roche Latest Developments

Table 112. GlaxoSmithKline Basic Information, Influenza Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 113. GlaxoSmithKline Influenza Drugs and Vaccines Product Offered

Table 114. GlaxoSmithKline Influenza Drugs and Vaccines Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 115. GlaxoSmithKline Main Business

Table 116. GlaxoSmithKline Latest Developments

Table 117. Novartis Basic Information, Influenza Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 118. Novartis Influenza Drugs and Vaccines Product Offered

Table 119. Novartis Influenza Drugs and Vaccines Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 120. Novartis Main Business

Table 121. Novartis Latest Developments

Table 122. Pfizer Basic Information, Influenza Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 123. Pfizer Influenza Drugs and Vaccines Product Offered

Table 124. Pfizer Influenza Drugs and Vaccines Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 125. Pfizer Main Business

Table 126. Pfizer Latest Developments

Table 127. Sanofi Pasteur Basic Information, Influenza Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 128. Sanofi Pasteur Influenza Drugs and Vaccines Product Offered

Table 129. Sanofi Pasteur Influenza Drugs and Vaccines Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 130. Sanofi Pasteur Main Business

Table 131. Sanofi Pasteur Latest Developments

Table 132. Bayer Basic Information, Influenza Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 133. Bayer Influenza Drugs and Vaccines Product Offered

Table 134. Bayer Influenza Drugs and Vaccines Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 135. Bayer Main Business

Table 136. Bayer Latest Developments

Table 137. Celgene Basic Information, Influenza Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 138. Celgene Influenza Drugs and Vaccines Product Offered

Table 139. Celgene Influenza Drugs and Vaccines Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 140. Celgene Main Business

Table 141. Celgene Latest Developments

Table 142. Seqirus Basic Information, Influenza Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 143. Seqirus Influenza Drugs and Vaccines Product Offered

Table 144. Seqirus Influenza Drugs and Vaccines Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 145. Seqirus Main Business

Table 146. Seqirus Latest Developments

Table 147. Protein Sciences Corporation Basic Information, Influenza Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 148. Protein Sciences Corporation Influenza Drugs and Vaccines Product Offered

Table 149. Protein Sciences Corporation Influenza Drugs and Vaccines Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 150. Protein Sciences Corporation Main Business

Table 151. Protein Sciences Corporation Latest Developments

Table 152. Serum Institute of India Basic Information, Influenza Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 153. Serum Institute of India Influenza Drugs and Vaccines Product Offered

Table 154. Serum Institute of India Influenza Drugs and Vaccines Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 155. Serum Institute of India Main Business

Table 156. Serum Institute of India Latest Developments

Table 157. Emergent Biosolutions Basic Information, Influenza Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 158. Emergent Biosolutions Influenza Drugs and Vaccines Product Offered

Table 159. Emergent Biosolutions Influenza Drugs and Vaccines Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 160. Emergent Biosolutions Main Business

Table 161. Emergent Biosolutions Latest Developments

Table 162. BioCryst Pharmaceuticals Basic Information, Influenza Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 163. BioCryst Pharmaceuticals Influenza Drugs and Vaccines Product Offered

Table 164. BioCryst Pharmaceuticals Influenza Drugs and Vaccines Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 165. BioCryst Pharmaceuticals Main Business

Table 166. BioCryst Pharmaceuticals Latest Developments

Table 167. Alvogen Basic Information, Influenza Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 168. Alvogen Influenza Drugs and Vaccines Product Offered

Table 169. Alvogen Influenza Drugs and Vaccines Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 170. Alvogen Main Business

Table 171. Alvogen Latest Developments

List of Figures

Figure 1. Picture of Influenza Drugs and Vaccines

Figure 2. Influenza Drugs and Vaccines Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Influenza Drugs and Vaccines Sales Growth Rate 2017-2028 (MT)

Figure 7. Global Influenza Drugs and Vaccines Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Influenza Drugs and Vaccines Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Influenza Drugs

Figure 10. Product Picture of Influenza Vaccines

Figure 11. Global Influenza Drugs and Vaccines Sales Market Share by Type in 2021

Figure 12. Global Influenza Drugs and Vaccines Revenue Market Share by Type (2017-2022)

Figure 13. Influenza Drugs and Vaccines Consumed in Hospital Pharmacy

Figure 14. Global Influenza Drugs and Vaccines Market: Hospital Pharmacy (2017-2022) & (MT)

Figure 15. Influenza Drugs and Vaccines Consumed in Retail Pharmacy

Figure 16. Global Influenza Drugs and Vaccines Market: Retail Pharmacy (2017-2022) & (MT)

Figure 17. Influenza Drugs and Vaccines Consumed in Online Pharmacy

Figure 18. Global Influenza Drugs and Vaccines Market: Online Pharmacy (2017-2022) & (MT)

Figure 19. Global Influenza Drugs and Vaccines Sales Market Share by Application (2017-2022)

Figure 20. Global Influenza Drugs and Vaccines Revenue Market Share by Application in 2021

Figure 21. Influenza Drugs and Vaccines Revenue Market by Company in 2021 ($ Million)

Figure 22. Global Influenza Drugs and Vaccines Revenue Market Share by Company in 2021

Figure 23. Global Influenza Drugs and Vaccines Sales Market Share by Geographic Region (2017-2022)

Figure 24. Global Influenza Drugs and Vaccines Revenue Market Share by Geographic Region in 2021

Figure 25. Global Influenza Drugs and Vaccines Sales Market Share by Region (2017-2022)

Figure 26. Global Influenza Drugs and Vaccines Revenue Market Share by Country/Region in 2021

Figure 27. Americas Influenza Drugs and Vaccines Sales 2017-2022 (MT)

Figure 28. Americas Influenza Drugs and Vaccines Revenue 2017-2022 ($ Millions)

Figure 29. APAC Influenza Drugs and Vaccines Sales 2017-2022 (MT)

Figure 30. APAC Influenza Drugs and Vaccines Revenue 2017-2022 ($ Millions)

Figure 31. Europe Influenza Drugs and Vaccines Sales 2017-2022 (MT)

Figure 32. Europe Influenza Drugs and Vaccines Revenue 2017-2022 ($ Millions)

Figure 33. Middle East & Africa Influenza Drugs and Vaccines Sales 2017-2022 (MT)

Figure 34. Middle East & Africa Influenza Drugs and Vaccines Revenue 2017-2022 ($ Millions)

Figure 35. Americas Influenza Drugs and Vaccines Sales Market Share by Country in 2021

Figure 36. Americas Influenza Drugs and Vaccines Revenue Market Share by Country in 2021

Figure 37. United States Influenza Drugs and Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 38. Canada Influenza Drugs and Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 39. Mexico Influenza Drugs and Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 40. Brazil Influenza Drugs and Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 41. APAC Influenza Drugs and Vaccines Sales Market Share by Region in 2021

Figure 42. APAC Influenza Drugs and Vaccines Revenue Market Share by Regions in 2021

Figure 43. China Influenza Drugs and Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 44. Japan Influenza Drugs and Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 45. South Korea Influenza Drugs and Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 46. Southeast Asia Influenza Drugs and Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 47. India Influenza Drugs and Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 48. Australia Influenza Drugs and Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 49. Europe Influenza Drugs and Vaccines Sales Market Share by Country in 2021

Figure 50. Europe Influenza Drugs and Vaccines Revenue Market Share by Country in 2021

Figure 51. Germany Influenza Drugs and Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 52. France Influenza Drugs and Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 53. UK Influenza Drugs and Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 54. Italy Influenza Drugs and Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 55. Russia Influenza Drugs and Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 56. Middle East & Africa Influenza Drugs and Vaccines Sales Market Share by Country in 2021

Figure 57. Middle East & Africa Influenza Drugs and Vaccines Revenue Market Share by Country in 2021

Figure 58. Egypt Influenza Drugs and Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 59. South Africa Influenza Drugs and Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 60. Israel Influenza Drugs and Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 61. Turkey Influenza Drugs and Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 62. GCC Country Influenza Drugs and Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 63. Manufacturing Cost Structure Analysis of Influenza Drugs and Vaccines in 2021

Figure 64. Manufacturing Process Analysis of Influenza Drugs and Vaccines

Figure 65. Industry Chain Structure of Influenza Drugs and Vaccines

Figure 66. Channels of Distribution

Figure 67. Distributors Profiles